Merck quarterly profit up 18 pct

May 5 (Reuters) - Merck & Co Inc reported an 18 percent rise in quarterly profit, driven by higher sales of diabetes drug Januvia and heart drug Zetia.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.